Advancing Patient-Centred Liver Cancer Care: DiCE at EASL Congress 2026
At EASL Congress 2026, DiCE championed meaningful patient involvement in research and care, highlighting the growing role of patient advocacy in sh...
ECO-POP Advances a New Vision for Personalised Colorectal Cancer Care
Partners from the ECO-POP project gathered in Oslo to review progress on three innovative colorectal cancer trials exploring more personalised, les...
EMERALD-3 Brings New Hope for People with Unresectable Liver Cancer
New results from the Phase III EMERALD-3 study offer encouraging news for people with unresectable liver cancer. By combining immunotherapy, target...
Biosimilars, Access, and the Future of Patient Care in Europe
Biosimilars are reshaping conversations around patient access, healthcare sustainability, and resilience across Europe. At the 2026 Biosimilar Medi...
Putting Patients at the Centre of Clinical Research: DiCE at READI’s Year One Milestone
DiCE joined partners at the READI General Assembly in Madrid, contributing to workshops, results discussions and planning for inclusive clinical re...
WHO Sounds the Alarm: Antibiotic Resistance Endangers Cancer Care
The World Health Organisation has sounded the alarm over a rising tide of antibiotic resistance, with one in six common bacterial infections worldw...
Supporting Your Mind: A Patient Guide Through Digestive Cancer
DiCE’s new guide offers practical tools to help patients manage the emotional impact of digestive cancer. Developed with patients, caregivers, an...
ILCM Patient Charter: A Global Call for Liver Cancer Rights
We proudly support the International Liver Cancer Movement (ILCM) and its first global Patient Charter for Hepatocellular Carcinoma (HCC). Together...
Strengthening Patient Advocacy: DiCE Team Training with Stefan Gijssels
DiCE hosted three days of training in Brussels, with Stefan Gijssels leading a powerful session on patient advocacy. The team collaborated in dynam...
Global Oncology Partnership Panel Focuses on Patient Engagement
Patient advocates gathered at the first Global Oncology Partnership Panel (GOPP) meeting hosted by Boehringer Ingelheim in Germany. Workshops and d...